Arcascope Inc.
- Headquarters
- CHANTILLY, VA
- Latest Form D
- $1.9M, Jun 2022
- Total capital
- $6.9M
- Federal grants
- $5M
- 9 awards · 2018–2025
- Private capital raised
- $1.9M
- 1 Form D · last Jun 2022
- 52 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 8 pending
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · Real-world translation of a dynamic and personalized intervention for shift workers$629K
- Federal grantDefense · Phase II · SBIR Phase II$997K
- Federal grantHealth and Human S · Phase II · Real-world translation of a dynamic and personalized intervention for shift workers$693K
- Federal grantHealth and Human S · Phase I · Feasibility of app-delivered circadian synchronization therapy with light in a cohort of pregnant women$295K
- Federal grantHealth and Human S · Phase I · Feasibility of a mobile application for sleep and circadian rhythms in pediatric patients with acute lymphoblastic leukemia and their caregivers$274K
- Private capital raisedForm D · SEC · 1st filing$1.9M
- Federal grantHealth and Human S · Phase I · Assessment of mobile application-delivered lighting interventions for reducing circadian disruption in shift workers$255K
Show 3 earlier federal awards
- Federal grantHealth and Human S · Phase II · Assessing the impact of app-delivered lighting interventions on fatigue in three populations of cancer patients$739K
- Federal grantHealth and Human S · Phase II · Assessing the impact of app-delivered lighting interventions on fatigue in three populations of cancer patients$873K
- Federal grantHealth and Human S · Phase I · Developing a mobile application for circadian wellness in cancer patients$221K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
45months
from Arcascope Inc.’s first federal award to its first private round.
- First federal award · Sep 2018
- Health and Human S · $221K
- First Form D · Jun 2022
- $1.9M · 1st Form D
- Awards before first raise
- 4 awards
An association in public records, not a cause or a prediction.
Founders and team
From SEC Form D filings- Daniel ForgerDirector, Executive OfficerNamed in SEC Form D filings
- Michael MastersonDirectorNamed in SEC Form D filings
- Olivia WalchDirector, Executive OfficerNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 8- PendingMethod for Optimizing an Entrainment of a Circadian CycleUSPTOApplication 18912127
- PendingMethod for Extracting Event Information from Calendar RepresentationsUSPTOApplication 18503014
- PendingSystem for Determining Treatment Timing and Methods of Treatment Timed Based on Biological Process IndicatorsUSPTOApplication 18310791
Show all 8 patent records
- Method for Optimizing an Entrainment of a Circadian CycleJan 30, 2025 · Application 18912127Pending
- Method for Extracting Event Information from Calendar RepresentationsJan 23, 2025 · Application 18503014Pending
- System for Determining Treatment Timing and Methods of Treatment Timed Based on Biological Process IndicatorsMay 9, 2024 · Application 18310791Pending
- Method To Minimize The Cost of Entraining A Target Limit CycleMar 7, 2024 · Application 17614985Pending
- Method for Extracting Event Information from Calendar RepresentationsApplication 63514519Pending
- System For Determining Treatment Timing And Methods Of Treatment Timed Based On Biological Process IndicatorsApplication PCTUS2023078484Pending
- System for Determining Treatment Timing and Methods of Treatment Timed Based on Biological Process IndicatorsApplication 63382856Pending
- Method To Minimize The Cost Of Entraining A Target Limit CycleApplication PCTUS2021035024Pending
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .